| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.063 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.3 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |